Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Critical Reviews in Oncology/Hematology|November 5, 2002
Ras as a target in cancer therapyRachel S Midgley, David J KerrExpert Review of Anticancer Therapy|February 25, 2003
Immunotherapy for colorectal cancerRachel S Midgley, David J KerrCurrent Opinion in Oncology|May 18, 2011
The emergence of 'omics for the management of colorectal cancerRachel S Midgley, David Church, David J KerrNature Clinical Practice. Gastroenterology & Hepatology|January 21, 2009
Evolution of nonsurgical therapy for colorectal cancerRachel S Midgley, Yoko Yanagisawa, David J KerrHepatology (Baltimore, Md.)|November 5, 2008
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinomaDaniel H Palmer, Rachel S Midgley, Noweeda Mirza, et al.Oncology (Williston Park, N.Y.)|May 17, 2002
Capecitabine/irinotecan combination regimens in colorectal cancerDavid J KerrNature Reviews. Clinical Oncology|September 3, 2014
Policy: EU data protection regulation--harming cancer researchDavid J KerrNature Clinical Practice. Oncology|November 3, 2005
Targeting angiogenesis in cancer: clinical development of bevacizumabDavid J KerrJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trialRachel S Midgley, Christopher C McConkey, Elaine C Johnstone, et al.Nature Clinical Practice. Oncology|October 22, 2008
Capecitabine: have we got the dose right?Rachel Midgley, David J KerrPageof 9